CVS Health Corporation (CVS) stock analysis
CVS · CVS Health Corporation
Latest recorded price: USD 88.61
Model-estimated fair value: USD 156.60. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Healthcare Plans
At $88.61, CVS trades 43.4% below the model's base-case value of $156.60. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $114.07 in the conservative case and $205.79 in the optimistic case, with a valuation confidence score of 83/100. About 71% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth 7.6%, free cash flow margin 1.9%, ROIC 3.0%. The model does not flag any risk signals for this company.